Agency Information Collection Activities; Proposed Collection; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, 30940-30942 [E6-8311]
Download as PDF
jlentini on PROD1PC65 with NOTICES
30940
Federal Register / Vol. 71, No. 104 / Wednesday, May 31, 2006 / Notices
previous dose of hepatitis A vaccine
should not get another dose.
• Anyone who has a severe (life
threatening) allergy to any vaccine
component should not get the vaccine.
Tell your doctor if you have any severe
allergies. All hepatitis A vaccines
contain alum and some hepatitis A
vaccines contain 2-phenoxyethanol.
• Anyone who is moderately or
severely ill at the time the shot is
scheduled should probably wait until
they recover. Ask your doctor or nurse.
People with a mild illness can usually
get the vaccine.
• Tell your doctor if you are pregnant.
The safety of hepatitis A vaccine for
pregnant women has not been
determined. But there is no evidence
that it is harmful to either pregnant
women or their unborn babies. The risk,
if any, is thought to be very low.
4. What are the risks from hepatitis A
vaccine?
A vaccine, like any medicine, could
possibly cause serious problems, such
as severe allergic reactions. The risk of
hepatitis A vaccine causing serious
harm, or death, is extremely small.
Getting hepatitis A vaccine is much
safer than getting the disease.
Mild problems.
• Soreness where the shot was given
(about 1 out of 2 adults, and up to 1 out
of 6 children).
• Headache (about 1 out of 6 adults
and 1 out of 25 children).
• Loss of appetite (about 1 out of 12
children).
• Tiredness (about 1 out of 14 adults).
If these problems occur, they usually
last 1 or 2 days.
Severe problems.
• Serious allergic reaction, within a
few minutes to a few hours of the shot
(very rare).
5. What if there is a moderate or
severe reaction?
What should I look for?
• Any unusual condition, such as a
high fever or behavior changes. Signs of
a serious allergic reaction can include
difficulty breathing, hoarseness or
wheezing, hives, paleness, weakness, a
fast heart beat or dizziness.
What should I do?
• Call a doctor, or get the person to
a doctor right away.
• Tell your doctor what happened,
the date and time it happened, and
when the vaccination was given.
• Ask your doctor, nurse, or health
department to report the reaction by
filing a Vaccine Adverse Event
Reporting System (VAERS) form.
Or you can file this report through the
VAERS Web site at https://
www.vaers.hhs.gov, or by calling 1–800–
822–7967.
VerDate Aug<31>2005
17:52 May 30, 2006
Jkt 208001
VAERS does not provide medical
advice.
6. The National Vaccine Injury
Compensation Program
In the event that you or your child has
a serious reaction to a vaccine, a federal
program has been created to help pay
for the care of those who have been
harmed.
For details about the National Vaccine
Injury Compensation Program, call 1–
800–338–2382 or visit their Web site at
https://www.hrsa.gov/
vaccinecompensation.
7. How can I learn more?
• Ask your doctor or nurse. They can
give you the vaccine package insert or
suggest other sources of information.
• Call your local or state health
department.
• Contact the Centers for Disease
Control and Prevention (CDC):
—Call 1–800–232–4636 (1–800–CDCINFO)
—Visit CDC Web sites at: https://
www.cdc.gov/hepatitis or https://
www.cdc.gov/nip
Department of Health and Human
Services, Centers for Disease Control
and Prevention, National Immunization
Program.
Vaccine Information Statement,
Hepatitis A (3/21/06), 42 U.S.C. 300aa–
26.
Dated: May 20, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–8350 Filed 5–30–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0202]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Prior Notice of
Imported Food Under the Public Health
Security and Bioterrorism
Preparedness and Response Act of
2002
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection provisions of
FDA’s regulations requiring that the
agency receive prior notice before food
is imported or offered for import into
the United States.
DATES: Submit written or electronic
comments on the collection of
information by July 31, 2006.
ADDRESSES: Submit electronic
comments on the collection of
information to: https://www.fda.gov/
dockets/ecomments. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–4659.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
E:\FR\FM\31MYN1.SGM
31MYN1
30941
Federal Register / Vol. 71, No. 104 / Wednesday, May 31, 2006 / Notices
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Prior Notice of Imported Food Under
the Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002—21 CFR 1.278 to
1.285 (OMB Control Number 0910–
0520)—Extension
The Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002 (the Bioterrorism
Act) added section 801(m) of the
Federal Food, Drug, and Cosmetic Act
(the act) (21 U.S.C. 381(m)), which
requires that FDA receive prior notice
for food, including food for animals,
that is imported or offered for import
into the United States. Sections 1.278 to
1.282 of FDA’s regulations (21 CFR
1.278 to 1.282) set forth the
requirements for submitting prior
notice; §§ 1.283(d) and 1.285(j) (21 CFR
1.283(d) and 1.285(j)) set forth the
procedure for requesting FDA review
after an article of food has been refused
admission under section 801(m)(1) of
the act or placed under hold under
section 801(l) of the act; and § 1.285(i)
(21 CFR 1.285(i)) sets forth the
procedure for post-hold submissions.
Advance notice of imported food allows
FDA, with the support of the Bureau of
Customs and Border Protection (CBP), to
target import inspections more
effectively and help protect the nation’s
food supply against terrorist acts and
other public health emergencies.
Any person with knowledge of the
required information may submit prior
notice for an article of food. Thus, the
respondents to this information
collection may include importers,
owners, ultimate consignees, shippers,
and carriers.
FDA’s regulations require that prior
notice of imported food be submitted
electronically using CBP’s Automated
Broker Interface of the Automated
Commercial System (ABI/ACS)
(§ 1.280(a)(1)) or the FDA Prior Notice
(PN) System Interface (Form FDA 3540)
(§ 1.280(a)(2)). The term ‘‘Form FDA
3540’’ refers to the electronic system
known as the FDA PN System Interface,
which is available at https://
www.access.fda.gov. Prior notice must
be submitted electronically using either
ABI/ACS or the FDA PN System
Interface. Information collected by FDA
in the prior notice submission includes:
The submitter and transmitter (if
different from the submitter); entry type
and CBP identifier; the article of food,
including complete FDA product code;
the manufacturer, for an article of food
no longer in its natural state; the grower,
if known, for an article of food that is
in its natural state; the FDA Country of
Production; the shipper, except for food
imported by international mail; the
country from which the article of food
is shipped or, if the food is imported by
international mail, the anticipated date
of mailing and country from which the
food is mailed; the anticipated arrival
information or, if the food is imported
by international mail, the U.S. recipient;
the importer, owner, and ultimate
consignee, except for food imported by
international mail or transshipped
through the United States; the carrier
and mode of transportation, except for
food imported by international mail;
and planned shipment information,
except for food imported by
international mail (§ 1.281).
Much of the information collected for
prior notice is identical to the
information collected for FDA’s
importer’s entry notice, which has been
approved under OMB control number
0910–0046. The information in FDA’s
importer’s entry notice is collected
electronically via CBP’s ABI/ACS at the
same time the respondent files an entry
for import with CBP. To avoid doublecounting the burden hours already
counted in the importer’s entry notice
information collection, the burden hour
analysis in table 1 of this document
reflects the reduced burden for prior
notice submitted through ABI/ACS in
the column labeled ‘‘Hours per
Response.’’
In addition to submitting a prior
notice, a submitter should cancel a prior
notice and must resubmit the
information if information changes after
FDA has confirmed a prior notice
submission for review (e.g., if the
identity of the manufacturer changes)
(§ 1.282). However, changes in the
estimated quantity, anticipated arrival
information, or planned shipment
information do not require resubmission
of prior notice after FDA has confirmed
a prior notice submission for review
(§ 1.282(a)(1)(i) to 1.282(a)(1)(iii)). In the
event that an article of food has been
refused admission under section
801(m)(1) or placed under hold under
section 801(l) of the act, §§ 1.283(d) and
1.285(j) set forth the procedure for
requesting FDA review and the
information required to be included in
a request for review. In the event that an
article of food has been placed under
hold under section 801(l) of the act,
§ 1.285(i) sets forth the procedure for
and the information to be included in a
post-hold submission.
FDA estimates the burden for this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
21 CFR Section No.
FDA Form No.
No. of
Respondents
Annual Frequency
per Respondent
Total Annual
Responses
Hours per
Response
Total Hours
Prior Notice Submissions
Prior notice submitted through ABI/ACS
None
6,500
949.50
6,171,750
0.167
1,030,6822
FDA 35403
1.280 to 1.281
214,400
8.33
1,785,952
0.384
685,806
Prior notice submitted through PNSI
1.280 to 1.281
jlentini on PROD1PC65 with NOTICES
New prior notice submissions subtotal
1,716,488
Prior Notice Cancellations
Prior notice cancelled through ABI/ACS
1.282
VerDate Aug<31>2005
FDA 3540
17:52 May 30, 2006
Jkt 208001
PO 00000
6,500
Frm 00085
Fmt 4703
3.34
Sfmt 4703
21,710
E:\FR\FM\31MYN1.SGM
31MYN1
0.25
5,428
30942
Federal Register / Vol. 71, No. 104 / Wednesday, May 31, 2006 / Notices
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1—Continued
21 CFR Section No.
FDA Form No.
No. of
Respondents
Annual Frequency
per Respondent
Total Annual
Responses
Hours per
Response
Total Hours
Prior notice cancelled through PNSI
1.282 and 1.283(a)(5)
FDA 3540
214,400
0.31
66,464
0.25
16,616
Prior notice cancellations subtotal
22,044
Prior Notice Requests for Review and Post-hold Submissions
1.283(d) and 1.285(j)
None
1
1
1
8
8
1.285(i)
None
1
1
1
1
1
Prior notice requests for review and post-hold submissions subtotal
9
Total hours annually
1,738,541
1There
are no capital costs or operating and maintenance costs associated with this collection of information.
avoid double-counting, an estimated 396,416 burden hours already accounted for in the importer’s entry notice information collection approved under OMB control number 0910–0046 are not included in this total.
3The term ‘‘Form FDA 3540’’ refers to the electronic system known as the FDA PN System Interface, which is available at https://
www.access.fda.gov.
jlentini on PROD1PC65 with NOTICES
2To
This estimate is based on FDA’s
experience and the average number of
prior notice submissions, cancellations,
and requests for review received in the
past 3 years.
FDA received 282,244 prior notices
through ABI/ACS during December
2003; 6,865,722 during 2004; and
6,171,939 during 2005. Based on this
experience, FDA estimates that
approximately 6,500 users of ABI/ACS
will submit an average of 949.5 prior
notices annually, for a total of 6,171,750
prior notices received annually through
ABI/ACS. FDA estimates the reporting
burden for a prior notice submitted
through ABI/ACS to be 10 minutes, or
0.167 hours, per notice, for a total
burden of 1,030,682 hours. This
estimate takes into consideration the
burden hours already counted in the
information collection approval for
FDA’s importer’s entry notice, as
previously discussed in this document.
FDA received 35,308 prior notices
through the PN System Interface during
December 2003; 1,425,825 during 2004;
and 1,786,896 during 2005. Based on
this experience, FDA estimates that
approximately 214,400 registered users
of the PN System Interface will submit
an average of 8.33 prior notices
annually, for a total of 1,785,952 prior
notices received annually through the
PN System Interface. FDA estimates the
reporting burden for a prior notice
submitted through the PN System
Interface to be 23 minutes, or 0.384
hours, per notice, for a total burden of
685,806 hours.
FDA received no cancellations of
prior notices through ABI/ACS during
December 2003; 16,624 during 2004;
and 21,720 during 2005. Based on this
VerDate Aug<31>2005
17:52 May 30, 2006
Jkt 208001
experience, FDA estimates that
approximately 6,500 users of ABI/ACS
will submit an average of 3.34
cancellations annually, for a total of
21,710 cancellations received annually
through ABI/ACS. FDA estimates the
reporting burden for a cancellation
submitted through ABI/ACS to be 15
minutes, or 0.25 hours, per cancellation,
for a total burden of 5,428 hours.
FDA received 1,539 cancellations of
prior notices through the PN System
Interface during December 2003; 64,918
during 2004; and 65,491 during 2005.
Based on this experience, FDA estimates
that approximately 214,400 registered
users of the PN System Interface will
submit an average of 0.31 cancellations
annually, for a total of 66,464
cancellations received annually through
the PN System Interface. FDA estimates
the reporting burden for a cancellation
submitted through the PN System
Interface to be 15 minutes, or 0.25
hours, per cancellation, for a total
burden of 16,616 hours.
FDA has not received any requests for
review under §§ 1.283(d) or 1.285(j) in
the last 3 years (December 2003 through
2005); therefore, the agency estimates
that one or fewer requests for review
will be submitted annually. FDA
estimates that it will take a requestor
about 8 hours to prepare the factual and
legal information necessary to prepare a
request for review. Thus, FDA has
estimated a total reporting burden of 8
hours.
FDA has not received any post-hold
submissions under § 1.285(i) in the last
3 years (December 2003 through 2005);
therefore, the agency estimates that one
or fewer post-hold submissions will be
submitted annually. FDA estimates that
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
it will take about 1 hour to prepare the
written notification described in
§ 1.285(i)(2)(i). Thus, FDA has estimated
a total reporting burden of 1 hour.
In cases where a regulation
implements a statutory information
collection requirement, only the
additional burden attributable to the
regulation, if any, has been included in
FDA’s burden estimate.
Dated: May 18, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–8311 Filed 5–30–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committe Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The cooperative
agreement applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
cooperative agreement application
review, the disclosure of which would
E:\FR\FM\31MYN1.SGM
31MYN1
Agencies
[Federal Register Volume 71, Number 104 (Wednesday, May 31, 2006)]
[Notices]
[Pages 30940-30942]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-8311]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0202]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Prior Notice of Imported Food Under the Public Health
Security and Bioterrorism Preparedness and Response Act of 2002
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the information collection
provisions of FDA's regulations requiring that the agency receive prior
notice before food is imported or offered for import into the United
States.
DATES: Submit written or electronic comments on the collection of
information by July 31, 2006.
ADDRESSES: Submit electronic comments on the collection of information
to: https://www.fda.gov/dockets/ecomments. Submit written comments on
the collection of information to the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Management
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the
[[Page 30941]]
information to be collected; and (4) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques, when appropriate, and other forms of
information technology.
Prior Notice of Imported Food Under the Public Health Security and
Bioterrorism Preparedness and Response Act of 2002--21 CFR 1.278 to
1.285 (OMB Control Number 0910-0520)--Extension
The Public Health Security and Bioterrorism Preparedness and
Response Act of 2002 (the Bioterrorism Act) added section 801(m) of the
Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 381(m)),
which requires that FDA receive prior notice for food, including food
for animals, that is imported or offered for import into the United
States. Sections 1.278 to 1.282 of FDA's regulations (21 CFR 1.278 to
1.282) set forth the requirements for submitting prior notice;
Sec. Sec. 1.283(d) and 1.285(j) (21 CFR 1.283(d) and 1.285(j)) set
forth the procedure for requesting FDA review after an article of food
has been refused admission under section 801(m)(1) of the act or placed
under hold under section 801(l) of the act; and Sec. 1.285(i) (21 CFR
1.285(i)) sets forth the procedure for post-hold submissions. Advance
notice of imported food allows FDA, with the support of the Bureau of
Customs and Border Protection (CBP), to target import inspections more
effectively and help protect the nation's food supply against terrorist
acts and other public health emergencies.
Any person with knowledge of the required information may submit
prior notice for an article of food. Thus, the respondents to this
information collection may include importers, owners, ultimate
consignees, shippers, and carriers.
FDA's regulations require that prior notice of imported food be
submitted electronically using CBP's Automated Broker Interface of the
Automated Commercial System (ABI/ACS) (Sec. 1.280(a)(1)) or the FDA
Prior Notice (PN) System Interface (Form FDA 3540) (Sec. 1.280(a)(2)).
The term ``Form FDA 3540'' refers to the electronic system known as the
FDA PN System Interface, which is available at https://
www.access.fda.gov. Prior notice must be submitted electronically using
either ABI/ACS or the FDA PN System Interface. Information collected by
FDA in the prior notice submission includes: The submitter and
transmitter (if different from the submitter); entry type and CBP
identifier; the article of food, including complete FDA product code;
the manufacturer, for an article of food no longer in its natural
state; the grower, if known, for an article of food that is in its
natural state; the FDA Country of Production; the shipper, except for
food imported by international mail; the country from which the article
of food is shipped or, if the food is imported by international mail,
the anticipated date of mailing and country from which the food is
mailed; the anticipated arrival information or, if the food is imported
by international mail, the U.S. recipient; the importer, owner, and
ultimate consignee, except for food imported by international mail or
transshipped through the United States; the carrier and mode of
transportation, except for food imported by international mail; and
planned shipment information, except for food imported by international
mail (Sec. 1.281).
Much of the information collected for prior notice is identical to
the information collected for FDA's importer's entry notice, which has
been approved under OMB control number 0910-0046. The information in
FDA's importer's entry notice is collected electronically via CBP's
ABI/ACS at the same time the respondent files an entry for import with
CBP. To avoid double-counting the burden hours already counted in the
importer's entry notice information collection, the burden hour
analysis in table 1 of this document reflects the reduced burden for
prior notice submitted through ABI/ACS in the column labeled ``Hours
per Response.''
In addition to submitting a prior notice, a submitter should cancel
a prior notice and must resubmit the information if information changes
after FDA has confirmed a prior notice submission for review (e.g., if
the identity of the manufacturer changes) (Sec. 1.282). However,
changes in the estimated quantity, anticipated arrival information, or
planned shipment information do not require resubmission of prior
notice after FDA has confirmed a prior notice submission for review
(Sec. 1.282(a)(1)(i) to 1.282(a)(1)(iii)). In the event that an
article of food has been refused admission under section 801(m)(1) or
placed under hold under section 801(l) of the act, Sec. Sec. 1.283(d)
and 1.285(j) set forth the procedure for requesting FDA review and the
information required to be included in a request for review. In the
event that an article of food has been placed under hold under section
801(l) of the act, Sec. 1.285(i) sets forth the procedure for and the
information to be included in a post-hold submission.
FDA estimates the burden for this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual Hours per
21 CFR Section No. FDA Form No. Respondents per Respondent Responses Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior Notice Submissions
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior notice submitted through ABI/ACS
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.280 to 1.281 None 6,500 949.50 6,171,750 0.167 1,030,682\2\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior notice submitted through PNSI
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.280 to 1.281 FDA 3540\3\ 214,400 8.33 1,785,952 0.384 685,806
--------------------------------------------------------------------------------------------------------------------------------------------------------
New prior notice submissions subtotal 1,716,488
-----------------------------------------------------------------------------------------------------------------------------------------
Prior Notice Cancellations
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior notice cancelled through ABI/ACS
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.282 FDA 3540 6,500 3.34 21,710 0.25 5,428
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 30942]]
Prior notice cancelled through PNSI
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.282 and 1.283(a)(5) FDA 3540 214,400 0.31 66,464 0.25 16,616
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior notice cancellations subtotal 22,044
-----------------------------------------------------------------------------------------------------------------------------------------
Prior Notice Requests for Review and Post-hold Submissions
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.283(d) and 1.285(j) None 1 1 1 8 8
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.285(i) None 1 1 1 1 1
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior notice requests for review and post-hold submissions subtotal 9
-----------------------------------------------------------------------------------------------------------------------------------------
Total hours annually 1,738,541
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\To avoid double-counting, an estimated 396,416 burden hours already accounted for in the importer's entry notice information collection approved
under OMB control number 0910-0046 are not included in this total.
\3\The term ``Form FDA 3540'' refers to the electronic system known as the FDA PN System Interface, which is available at https://www.access.fda.gov.
This estimate is based on FDA's experience and the average number
of prior notice submissions, cancellations, and requests for review
received in the past 3 years.
FDA received 282,244 prior notices through ABI/ACS during December
2003; 6,865,722 during 2004; and 6,171,939 during 2005. Based on this
experience, FDA estimates that approximately 6,500 users of ABI/ACS
will submit an average of 949.5 prior notices annually, for a total of
6,171,750 prior notices received annually through ABI/ACS. FDA
estimates the reporting burden for a prior notice submitted through
ABI/ACS to be 10 minutes, or 0.167 hours, per notice, for a total
burden of 1,030,682 hours. This estimate takes into consideration the
burden hours already counted in the information collection approval for
FDA's importer's entry notice, as previously discussed in this
document.
FDA received 35,308 prior notices through the PN System Interface
during December 2003; 1,425,825 during 2004; and 1,786,896 during 2005.
Based on this experience, FDA estimates that approximately 214,400
registered users of the PN System Interface will submit an average of
8.33 prior notices annually, for a total of 1,785,952 prior notices
received annually through the PN System Interface. FDA estimates the
reporting burden for a prior notice submitted through the PN System
Interface to be 23 minutes, or 0.384 hours, per notice, for a total
burden of 685,806 hours.
FDA received no cancellations of prior notices through ABI/ACS
during December 2003; 16,624 during 2004; and 21,720 during 2005. Based
on this experience, FDA estimates that approximately 6,500 users of
ABI/ACS will submit an average of 3.34 cancellations annually, for a
total of 21,710 cancellations received annually through ABI/ACS. FDA
estimates the reporting burden for a cancellation submitted through
ABI/ACS to be 15 minutes, or 0.25 hours, per cancellation, for a total
burden of 5,428 hours.
FDA received 1,539 cancellations of prior notices through the PN
System Interface during December 2003; 64,918 during 2004; and 65,491
during 2005. Based on this experience, FDA estimates that approximately
214,400 registered users of the PN System Interface will submit an
average of 0.31 cancellations annually, for a total of 66,464
cancellations received annually through the PN System Interface. FDA
estimates the reporting burden for a cancellation submitted through the
PN System Interface to be 15 minutes, or 0.25 hours, per cancellation,
for a total burden of 16,616 hours.
FDA has not received any requests for review under Sec. Sec.
1.283(d) or 1.285(j) in the last 3 years (December 2003 through 2005);
therefore, the agency estimates that one or fewer requests for review
will be submitted annually. FDA estimates that it will take a requestor
about 8 hours to prepare the factual and legal information necessary to
prepare a request for review. Thus, FDA has estimated a total reporting
burden of 8 hours.
FDA has not received any post-hold submissions under Sec. 1.285(i)
in the last 3 years (December 2003 through 2005); therefore, the agency
estimates that one or fewer post-hold submissions will be submitted
annually. FDA estimates that it will take about 1 hour to prepare the
written notification described in Sec. 1.285(i)(2)(i). Thus, FDA has
estimated a total reporting burden of 1 hour.
In cases where a regulation implements a statutory information
collection requirement, only the additional burden attributable to the
regulation, if any, has been included in FDA's burden estimate.
Dated: May 18, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-8311 Filed 5-30-06; 8:45 am]
BILLING CODE 4160-01-S